Ag Novartis, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 5,353 shares at $25.14 ($135K) on 2017-05-26, disclosed to the SEC on 2017-05-30.
Open-market sale of $135k RARX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 53 | $1K | 1.0% |
| 2 | $25.14 | 5,300 | $133K | 99.0% |
| Total | $25.14 avg | 5,353 | $135K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-12 | $242K | — | Filing → |
| GRTX | BUY | 2019-11-12 | $3.0M | — | Filing → |
| ARPO | SELL | 2019-04-29 | $1.4M | — | Filing → |